Skip to main content
161 search results for:

Hydroxychloroquine 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 29-09-2022 | Systemic lupus erythematosus | News | Article

    Reduced-dose hydroxychloroquine linked to higher flare risk in SLE

    Research suggests that using a daily hydroxychloroquine dose of 5 mg/kg or lower, as recommended by ophthalmology guidelines, is associated with an increased risk for systemic lupus erythematosus flares compared with higher doses.

  2. 19-08-2022 | Rheumatoid arthritis | News | Article

    Caution needed with hydroxychloroquine use in older RA patients with heart failure

    Hydroxychloroquine is not associated with an overall increased risk for sudden cardiac arrest or ventricular arrhythmia or major adverse cardiovascular events relative to methotrexate among older people with rheumatoid arthritis, study findings suggest.

  3. 12-01-2021 | COVID-19 | Podcast | Article

    Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine

    Alfred Kim talks about the initial promise of hydroxychloroquine for COVID-19 and why it did not stand up to later scrutiny (13:06).

  4. 11-01-2021 | COVID-19 | Podcast | Teaser
    Featured podcast

    Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine

    Alfred Kim talks about the initial promise of hydroxychloroquine for COVID-19 and why it did not stand up to later scrutiny (13:06).

  5. 06-01-2021 | Systemic lupus erythematosus | News | Article

    Hydroxychloroquine blood monitoring may predict thrombosis risk in SLE

    Among patients with systemic lupus erythematosus receiving treatment with hydroxychloroquine, low drug levels in the blood are associated with an elevated risk for arterial and venous thrombosis events, researchers report.

  6. 06-01-2021 | Systemic lupus erythematosus | Highlight | Teaser
    medwireNews top story

    Hydroxychloroquine blood monitoring may predict thrombosis risk in SLE

    Among patients with systemic lupus erythematosus receiving treatment with hydroxychloroquine, low drug levels in the blood are associated with an elevated risk for arterial and venous thrombosis events, researchers report.

  7. 26-11-2020 | COVID-19 | Teaser
    medwireNews top story

    Further evidence against hydroxychloroquine use for prevention, treatment of COVID-19

    Findings from two randomized trials provide further evidence to suggest that hydroxychloroquine has no benefits for the prevention or treatment of COVID-19.

  8. 26-11-2020 | COVID-19 | Highlight | Teaser
    Spotlight on: Repurposing rheumatology drugs for COVID-19

    Further evidence against hydroxychloroquine use for prevention, treatment of COVID-19

    Findings from two randomized trials provide further evidence to suggest that hydroxychloroquine has no benefits for the prevention or treatment of COVID-19.

  9. 26-11-2020 | COVID-19 | News | Article

    Further evidence against hydroxychloroquine use for prevention, treatment of COVID-19

    Findings from two randomized trials provide further evidence to suggest that hydroxychloroquine has no benefits for the prevention or treatment of COVID-19.

  10. 13-10-2020 | COVID-19 | Highlight | Teaser
    Spotlight on: Repurposing rheumatology drugs for COVID-19

    RECOVERY: Hydroxychloroquine does not prevent COVID-19 deaths

    Treatment with hydroxychloroquine does not reduce 28-day mortality risk among patients hospitalized with COVID-19, show results from the large-scale UK-based RECOVERY trial.

  11. 13-10-2020 | COVID-19 | News | Article

    RECOVERY: Hydroxychloroquine does not prevent COVID-19 deaths

    Treatment with hydroxychloroquine does not reduce 28-day mortality risk among patients hospitalized with COVID-19, show results from the large-scale UK-based RECOVERY trial.

  12. 23-11-2020 | COVID-19 | News | Article

    No reduction in COVID-19 mortality risk with routine hydroxychloroquine use in RMD patients

    Use of hydroxychloroquine for the treatment of rheumatic and musculoskeletal diseases is not associated with a reduction in COVID-19 mortality risk, suggest findings from an observational study published in The Lancet Rheumatology .

  13. 03-04-2020 | COVID-19 | News | Article

    Rheumatologists urge caution on chloroquine, hydroxychloroquine use for COVID-19

    Rheumatologists highlight that more research needs to be carried out before chloroquine and hydroxychloroquine can be recommended for the treatment of COVID-19, and emphasize the need for adequate supplies of these agents for people with rheumatic diseases.

  14. 27-04-2020 | COVID-19 | News | Article
    Regulatory update

    COVID-19: FDA warns against chloroquine, hydroxychloroquine use outside specific settings

    The US FDA has issued a safety alert warning that chloroquine and hydroxychloroquine for COVID-19 should not be used outside of hospital settings or clinical trials due to an elevated risk for heart rhythm problems with the agents.

  15. 17-04-2020 | COVID-19 | News | Article
    News in brief

    ‘Dearth of evidence’ to support prophylactic chloroquine, hydroxychloroquine use for COVID-19

    Findings from a systematic review published in the International Journal of Rheumatic Diseases confirm that there is currently insufficient evidence to support the efficacy of chloroquine or hydroxychloroquine for the prevention of COVID-19.

  16. 02-10-2020 | COVID-19 | Highlight | Teaser
    Spotlight on: Repurposing rheumatology drugs for COVID-19

    PATCH trial shows ‘no clinical benefit’ of hydroxychloroquine for COVID-19 prophylaxis

    Prophylactic use of hydroxychloroquine does not reduce the risk for SARS-CoV-2 infection among hospital-based healthcare workers at high risk for exposure, suggest findings from a randomized controlled trial.

  17. 13-05-2020 | Systemic lupus erythematosus | News | Article
    News in brief

    Hydroxychloroquine use does not protect against severe COVID-19 in people with lupus

    Data from the COVID-19 Global Rheumatology Alliance provide further evidence against a protective effect of hydroxychloroquine on the development of severe COVID-19 in patients with systemic lupus erythematosus.

  18. 30-09-2020 | COVID-19 | News | Article

    PATCH trial shows ‘no clinical benefit’ of hydroxychloroquine for COVID-19 prophylaxis

    Prophylactic use of hydroxychloroquine does not reduce the risk for SARS-CoV-2 infection among hospital-based healthcare workers at high risk for exposure, suggest findings from a randomized controlled trial.

  19. 30-09-2020 | COVID-19 | News | Article

    Hydroxychloroquine use may not lower COVID-19 risk in people with RMDs

    Long-term hydroxychloroquine treatment is not associated with a reduced risk for developing COVID-19 among patients with rheumatic and musculoskeletal diseases, research suggests.

  20. 03-08-2020 | COVID-19 | News | Article
    News in brief

    Further evidence against hydroxychloroquine use for COVID-19

    The addition of hydroxychloroquine to standard care does not result in better clinical outcomes among hospitalized patients with mild-to-moderate COVID-19, say the Coalition Covid-19 Brazil I investigators.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.